36C77026Q0061_1.docx

36C77026Q0061

GENERAL INFORMATION

SET-ASIDE

Network Contracting Office 15 (NCO 15) 3450 S. 4th St. Trafficway

Leavenworth KS 66048-5012

POINT OF CONTACT*

Contract Specialist McAlhaney, Michael W.

Michael.McAlhaney@va.gov

(913) 684-1976

PLACE OF PERFORMANCE

Multiple Locations

POSTAL CODE

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

Sources Sought Notice Sources Sought Notice

DESCRIPTION

Sources Sought Notice

Request for Information (RFI):

Domestic Pharmaceutical Manufacturing 36C77026Q0061

1. Overview The Department of Veterans Affairs (VA), Consolidated Mail Outpatient Pharmacy (CMOP) operates seven sites across the United States, supporting the daily mailout of approximately 450,000 prescriptions to Veterans. While the majority of these prescriptions are fulfilled through the Prime Vendor contract, CMOP supplements its supply through Open Market (OM) purchases when necessary, through solicitations that get published to the System for Award Management (SAM) website, similar to how this RFI is being published.

To support these OM requirements, the Government has an ongoing need to identify pharmaceutical end items manufactured, processed, or produced by domestic small and large businesses. This RFI is issued solely for market research and procurement planning purposes and does not constitute a Request for Quote (RFQ) or Request for Proposal (RFP). This notice shall not be construed as a commitment by the Government to ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. This request does not constitute a solicitation for proposals or quotes or the authority to enter into negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. Related details can be found in section six (6) regarding the nature of this RFI.

2. Purpose The purpose of this RFI is to:

· Identify domestic small and large business pharmaceutical manufacturers with efficient production capabilities related to FAR Part 12 Acquisition of Commercial Products and Commercials Services in combination with FAR Part 25 Foreign Acquisition procedures.

· Gather information on manufacturers of pharmaceuticals and ancillary items related to CMOP’s OM purchases.

· Promote early exchanges of information in accordance with Federal Acquisition Regulation (FAR) Overhaul Part 15.101, to improve mutual understanding of Government needs and industry capabilities.

· Deeper Insight into Small Business type considerations in manufacturing to include all socio-economic considerations with the highest interest in Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Business (VOSB) Manufacturers.

3. Scope The overall intent of the RFI is to provide outreach within the designated NAICS codes:

· 325412 - Pharmaceutical Preparation Manufacturing

· 325413 - In-Vitro Diagnostic Substance Manufacturing The list presented below is not exhaustive of pharmaceutical and medical surgical items that may be required in Fiscal Year (FY) 26 and is subject to be updated periodically as our requirements change.

CMOP is seeking information from both small and large domestic manufacturers capable of providing the following items to support CMOP’s OM needs:

4. Submission Guidelines If your company manufactures pharmaceuticals that are not listed above and are produced domestically in accordance with (IAW) FAR Part 25.001(c), please provide the following information:

· Company Information:

· Name, physical address, and point of contact

· Physical address of domestic manufacturing facility

· Socioeconomic status (e.g., SDVOSB, VOSB, 8(a), etc.) to include both large and small business types

· Business size and SAM UEI Number

· Product Information:

· List of domestically manufactured pharmaceuticals

· FDA-approved NDC numbers

· Treatment usage of each pharmaceutical

· Authorized distributors

· Average cost for common prescription quantities

· Operational Capability:

· Manufacturing facility production capacity (volume)

· Frequency of stockouts in the past 12 months

· Typical replenishment timelines

· Commercial entities where the items have been sold to for ultimate large volume dispensing.

· Contracting Information:

· GSA/FSS/NAC contract numbers (if applicable)

· Suggested alternative NAICS or PSC codes, if more appropriate

· Compliance:

Any manufacturer responding to this announcement must be able to show their capability to comply with:

· Ability to meet federal, state, and local regulations

· Capacity to support all seven CMOP sites if needed

· Interested manufacturers are reminded that in accordance with FAR 4.12, prospective contractors shall complete electronic annual representations and certifications in conjunction with FAR 4.11 required registration in the System for Award Management (SAM) database prior to award of a contract.

5. Response Instructions:

If you believe you are capable of meeting the requirement, please provide a complete capability statement and response by March 15, 2026, at 4:30 pm CT to:

Michael McAlhaney Email: michael.mcalhaney@va.gov Tresanna Tacia Email: tresanna.tacia@va.gov

Subject Line of Email: Must start with the 1) RFI Number 36C77026Q0061 followed by the 2) generic pharmaceutical name. The proprietary name should only be used when there are no FDA approved generic options.

Use the Excel Spreadsheet inputs as identified as “Manufacturer Inputs_Excel” as part of a complete submission.

6. Important Notice PLEASE NOTE: This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Respondents are solely responsible for all expenses associated with responding to this RFI. The Government does not intend to award a contract on the basis of the RFI or otherwise pay for the information requested. Responses will be treated as information only and not as a proposal.

DISCLAIMER

This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.

See attached document: P02_Sources Sought_Attch1_Manufacturer Inputs_Excel.

Page 1 of